Tirzepatide as a Research Tool for Studying GLP-1 and GIP Signaling Pathways
Introduction Tirzepatide is a dual incretin receptor agonist widely used in metabolic and endocrine research to investigate GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) signaling pathways. In experimental systems, it is not treated as a therapeutic agent, but as a molecular probe for studying how incretin hormones regulate glucose metabolism, insulin secretion, and energy …
Tirzepatide as a Research Tool for Studying GLP-1 and GIP Signaling Pathways Read More »
